Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannik Severin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scientific Reports|February 15, 2019
In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis AssayDaniel Schulz, Yannik Severin, Vito Riccardo Tomaso Zanotelli, et al.
Science Advances|November 2, 2022
Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypesYannik Severin, Benjamin D Hale, Julien Mena, et al.
Plos Pathogens|May 3, 2014
A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonizationStefanie Baur, Maren Rautenberg, Michaela Faulstich, et al.
Nature|August 3, 2022
A physical wiring diagram for the human immune systemJarrod Shilts, Yannik Severin, Francis Galaway, et al.
Nature Cancer|April 20, 2023
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivsek, Paul Kachel, Sandra Goetze, et al.
Science (New York, N.Y.)|June 6, 2024
Cellular architecture shapes the naïve T cell responseBenjamin D Hale, Yannik Severin, Fabienne Graebnitz, et al.
Blood Cancer Discovery|September 20, 2022
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision MedicineTim Heinemann, Christoph Kornauth, Yannik Severin, et al.
Nature Communications|December 3, 2021
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networksMaik Müller, Fabienne Gräbnitz, Niculò Barandun, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Science Advances|July 3, 2024
Targeting IL-1 controls refractory pityriasis rubra pilarisEloi Schmauch, Yannik Severin, Xianying Xing, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scientific Reports|February 15, 2019
In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis AssayDaniel Schulz, Yannik Severin, Vito Riccardo Tomaso Zanotelli, et al.
Science Advances|November 2, 2022
Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypesYannik Severin, Benjamin D Hale, Julien Mena, et al.
Plos Pathogens|May 3, 2014
A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonizationStefanie Baur, Maren Rautenberg, Michaela Faulstich, et al.
Nature|August 3, 2022
A physical wiring diagram for the human immune systemJarrod Shilts, Yannik Severin, Francis Galaway, et al.
Nature Cancer|April 20, 2023
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivsek, Paul Kachel, Sandra Goetze, et al.
Science (New York, N.Y.)|June 6, 2024
Cellular architecture shapes the naïve T cell responseBenjamin D Hale, Yannik Severin, Fabienne Graebnitz, et al.
Blood Cancer Discovery|September 20, 2022
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision MedicineTim Heinemann, Christoph Kornauth, Yannik Severin, et al.
Nature Communications|December 3, 2021
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networksMaik Müller, Fabienne Gräbnitz, Niculò Barandun, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Science Advances|July 3, 2024
Targeting IL-1 controls refractory pityriasis rubra pilarisEloi Schmauch, Yannik Severin, Xianying Xing, et al.
Pageof 1